The Board assumes fiduciary responsibility for the TB Alliance and guides its business strategy, actions, and budget. A Chief Executive Officer leads the organization and is a member of the Board.
The Board consists of thirteen directors, elected for staggered three-year terms, and represents government agencies, pharmaceutical and biotechnology companies, private foundations, and non-governmental organizations.
An elected member of the Stakeholders Association serves as an ex-officio member of the Board of Directors.
|
|
Board of Directors
- Dr. Bruce Carter | Chair
Executive Director, Immune Design
- Dr. Jaap F. Broekmans
KNCV Tuberculosis Foundation
- Dr. Jan Gheuens
Senior Program Officer, Infectious Disease Development, Bill & Melinda Gates Foundation
- Dr. Simba Gill
Chief Executive Officer, moksha8 Pharmaceuticals
- Ms. Julia Gregory
President & Chief Executive Officer, Five Prime Therapeutics
- Mr. Mark Kessel
Managing Director, Symphony Capital LLC
- Dr. Anthony MBewu
Global Forum for Health Research
- Dr. Carlos Morel
Director, Center for Technological Development in Health (CDTS), Oswaldo Cruz Foundation (FIOCRUZ)
- Dr. Lee Reichman
Executive Director, Global Tuberculosis Center, New Jersey Medical School
- Dr. George A. Scangos
President and Chief Executive Officer, Exelixis
- Dr. Melvin Spigelman
President & Chief Executive Officer, Global Alliance for TB Drug Development
- Dr. Maarten van Cleeff | ex officio
Project Director,The Tuberculosis Coalition for Technical Assistance (TBCTA), KNCV Tuberculosis Foundation
Former Directors
- Dr. Olusoji Adeyi
Director, Affordable Medicines Facility-malaria (AMFm), Global Fund to Fight AIDS, Tuberculosis & Malaria
- Dr. Gail Cassell
Vice President, Scientific Affairs, Eli Lilly and Company
- Dr. Gijs Elzinga
Deputy Director-General, Netherlands' National Institute of Public Health and the Environment
- Dr. Paul Herrling
Head of Corporate Research, Novartis International AG
- Mr. Charles Kaye
Co-President, Warburg Pincus
- Dr. John La Montagne
Deputy Director, U.S. National Institute of Allergy and Infectious Diseases/National Institutes of Health (deceased)
- Mr. Seán Lance
Chairman of the Board, Chiron Corporation (retired)
- Dr. Malegapuru William Makgoba
Vice Chancellor and Principal, University of Natal
- Mr. James Orbinski | Former President, TB Alliance Stakeholders' Association
Saul Rae Fellow, The Munk Center for International Studies and Center for Global Research, Massey College
- Dr. Ariel Pablos-Méndez
Director, Knowledge Management and Sharing, World Health Organization
- Dr. K. Anji Reddy
Chairman, Dr. Reddy's Laboratories Ltd.
- Mr. Parag Saxena
CEO & Managing Member, Vedanta Capital
- Dr. Peter Small
Senior Program Officer for Tuberculosis, Global Health Program, Bill & Melinda Gates Foundation
- Prof. Petro Terblanche | Former President, TB Alliance Stakeholders' Association
Director, Tuberculosis Center of Competence, Cape Biotech Trust
- Dr. Thelma Tupasi-Ramos
President, Tropical Disease Foundation
- Sir David Weatherall
Founding Director Emeritus, Weatherall Institute of Molecular Medicine, University of Oxford
- Dr. Charles Yu | Former President, TB Alliance Stakeholders' Association
Chairman, Philippines Coalition Against Tuberculosis (PhilCAT)
|
